Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.65 Insider Own0.20% Shs Outstand154.07M Perf Week0.00%
Market Cap499.19M Forward P/E- EPS next Y-0.65 Insider Trans0.00% Shs Float141.53M Perf Month-14.06%
Income-92.80M PEG- EPS next Q-0.16 Inst Own91.20% Short Float11.49% Perf Quarter-10.00%
Sales137.90M P/S3.62 EPS this Y-4.60% Inst Trans-4.15% Short Ratio7.65 Perf Half Y29.08%
Book/sh-0.10 P/B- EPS next Y4.40% ROA-49.40% Target Price7.83 Perf Year-44.52%
Cash/sh- P/C- EPS next 5Y10.00% ROE- 52W Range2.38 - 6.04 Perf YTD-23.22%
Dividend- P/FCF- EPS past 5Y8.60% ROI- 52W High-46.36% Beta2.11
Dividend %- Quick Ratio- Sales past 5Y13.90% Gross Margin83.20% 52W Low36.13% ATR0.21
Employees156 Current Ratio- Sales Q/Q251.20% Oper. Margin-59.70% RSI (14)40.60 Volatility5.99% 6.31%
OptionableYes Debt/Eq- EPS Q/Q-93.60% Profit Margin-67.30% Rel Volume0.74 Prev Close3.17
ShortableYes LT Debt/Eq- EarningsAug 04 BMO Payout- Avg Volume2.13M Price3.24
Recom1.50 SMA20-12.61% SMA50-10.70% SMA200-5.34% Volume1,574,650 Change2.21%
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Oct-09-07Initiated Lehman Brothers Overweight $16
Aug-13-07Initiated Rodman & Renshaw Mkt Outperform $18
May-23-07Initiated JP Morgan Overweight
Jan-04-07Reiterated Piper Jaffray Outperform $14 → $20
Aug-25-16 01:04PM  ARRAY BIOPHARMA INC Financials
Aug-23-16 11:20AM  ETFs with exposure to Array BioPharma, Inc. : August 23, 2016
Aug-22-16 09:40AM  Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016 +6.48%
Aug-19-16 03:26PM  Array BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress PR Newswire -6.90%
08:32AM  ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report
Aug-14-16 10:05AM  Top 6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Aug-11-16 12:31PM  ETFs with exposure to Array BioPharma, Inc. : August 11, 2016
Aug-10-16 12:54PM  Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 10, 2016
10:55AM  Shareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Array BioPharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
08:14AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : August 10, 2016
Aug-09-16 03:37PM  Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial -22.70%
11:05AM  3 Biotech Stocks With Catalysts That Have 90% to 500% Upside Potential at 24/7 Wall St.
07:40AM  Array BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals at MarketWatch
06:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:01AM  AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer PR Newswire
Aug-05-16 03:00PM  Edited Transcript of ARRY earnings conference call or presentation 4-Aug-16 1:00pm GMT
08:25AM  Array BioPharma (ARRY) in Focus: Stock Moves 9.3% Higher
Aug-04-16 09:11AM  Array BioPharma reports 4Q loss +9.27%
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:00AM  Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 PR Newswire
07:07AM  Q4 2016 Array Biopharma Inc Earnings Release - Before Market Open
Aug-03-16 05:05PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jul-28-16 08:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:00AM  Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer PR Newswire
Jul-27-16 04:56PM  Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 On August 4, 2016 PR Newswire
Jul-18-16 09:32AM  Biotech Equities Technical Briefing on Array BioPharma, Geron, Emergent BioSolutions, and Global Blood Therapeutics
Jul-07-16 06:36PM  Array BioPharma To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference PR Newswire
Jul-01-16 12:33PM  Why These Stocks Are Trending on Friday at Insider Monkey
08:37AM  Why Array Is Making a Run at 24/7 Wall St.
Jun-30-16 04:03PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:00PM  Array BioPharma Submits Binimetinib New Drug Application to U.S. FDA PR Newswire
Jun-28-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : June 28, 2016
Jun-17-16 11:52AM  Array BioPharma, Inc. Value Analysis (NASDAQ:ARRY) : June 17, 2016
Jun-16-16 08:18AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : June 16, 2016
Jun-09-16 10:27AM  Here's Why Array Biopharma Inc. Gained 18.1% in May at Motley Fool
Jun-08-16 10:10AM  All You Need To Know About Array Biopharma Inc (ARRY)s Upcoming NDA Submission at Insider Monkey
Jun-06-16 02:20PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:15PM  Array Presents Full Results from Phase 3 NEMO Study PR Newswire
Jun-04-16 09:00AM  Encorafenib-based Regimens Provide Improved PFS and OS in Difficult-to-Treat BRAF-Mutant Colorectal Cancer Compared to Historical Benchmarks PR Newswire
09:00AM  Array BioPharma, Pierre Fabre and Merck KGaA, Darmstadt, Germany Announce Phase 3 BEACON CRC Trial PR Newswire
Jun-03-16 09:30AM  Redmile Group Sticking With Healthcare Picks After Rough Q1 at Insider Monkey
Jun-02-16 02:20PM  Array BioPharma To Present At The Jefferies 2016 Global Healthcare Conference PR Newswire
May-31-16 12:31PM  Most Popular Healthcare Stocks Under $5 at Insider Monkey
May-26-16 07:10PM  ETFs with exposure to Array BioPharma, Inc. : May 26, 2016
May-23-16 08:15AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : May 23, 2016
May-18-16 05:26PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:05PM  Array BioPharma Announces Key Data from NRAS-mutant Melanoma and BRAF-mutant Colorectal Cancer ASCO 2016 Presentations PR Newswire
May-09-16 08:30AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : May 9, 2016
May-05-16 07:00PM  Array BioPharma To Present At The Bank of America Merrill Lynch HealthCare Conference PR Newswire
May-04-16 05:44PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
01:12AM  Edited Transcript of ARRY earnings conference call or presentation 4-May-15 1:00pm GMT
May-03-16 09:03PM  Edited Transcript of ARRY earnings conference call or presentation 3-May-16 1:00pm GMT
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:46AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
08:16AM  Array BioPharma reports 3Q loss AP
08:00AM  Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2016 PR Newswire
07:07AM  Q3 2016 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Apr-26-16 12:25PM  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2016 On May 3, 2016 PR Newswire
Apr-25-16 09:36AM  Why Patents are the Lifeblood of Biotech Companies Accesswire
Apr-17-16 05:17PM  Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study at TheStreet
Apr-01-16 09:41AM  Array Bio ends late-stage study of ovarian cancer drug Reuters
09:16AM  Array Bio stops study testing drug for ovarian cancer Reuters
09:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Array BioPharma Announces Decision To Discontinue MILO Study In Ovarian Cancer PR Newswire
Mar-31-16 09:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Array BioPharma And Asahi Kasei Pharma Corporation Announce Development And Commercialization Collaboration For Novel Pain And Inflammation Program PR Newswire
Mar-24-16 03:51PM  Five Cheap Healthcare Stocks With Hedge Fund Support at Insider Monkey +5.15%
Mar-23-16 08:28AM  Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : March 23, 2016 -7.48%
Mar-09-16 08:13AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : March 9, 2016
Mar-08-16 08:47AM  Array Biopharma draws upside position -6.33%
Mar-01-16 12:53PM  Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference PR Newswire +6.77%
Feb-29-16 05:05AM  Edited Transcript of ARRY earnings conference call or presentation 3-Feb-15 2:00pm GMT
Feb-16-16 09:00AM  Small Cap Acquisition Candidates See Increased Investor Interest Accesswire +8.02%
Feb-08-16 08:00AM  Biotechnology Stocks Technical Review -- MannKind, Array BioPharma, Arena Pharma, and Chimerix Accesswire -9.97%
Feb-05-16 04:12PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
Feb-02-16 02:00PM  Edited Transcript of ARRY earnings conference call or presentation 2-Feb-16 2:00pm GMT
12:00PM  Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference PR Newswire
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
07:30AM  Array BioPharma reports 2Q loss
07:07AM  Q2 2016 Array Biopharma Inc Earnings Release - Before Market Open
07:04AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:00AM  Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2016 PR Newswire
Feb-01-16 12:21PM  Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma at noodls
11:55AM  Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma PR Newswire
Jan-27-16 02:00PM  Fate (FATE) to Move ProTmune into Phase I/II Study in Mid-16
Jan-26-16 02:52PM  Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2, 2016 at noodls
02:31PM  Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2, 2016 PR Newswire
Jan-13-16 09:02AM  5 Stocks Insiders Love Right Now at TheStreet -7.54%
Jan-12-16 01:07PM  Buffett, Starboard Among the Elite Investors to Disclose New Moves at Insider Monkey
Jan-11-16 04:05PM  QIAGEN Reaches Milestone With Portfolio of Master Collaboration Agreements for Pharma Companion Diagnostics PR Newswire
Jan-06-16 10:00AM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire -5.56%
08:33AM  Will Array BioPharma (ARRY) Crush Estimates at Its Next Earnings Report?
Dec-23-15 08:34AM  Why Array BioPharma (ARRY) Could Be Positioned for a Surge?
Dec-22-15 08:07AM  Array Reports Positive Results from Its Phase 3 Study
Dec-21-15 10:11AM  Array BioPharma, Inc. Earnings Analysis: Q1, 2016 By the Numbers
08:59AM  Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : December 21, 2015
07:13AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Array Announces Closing Of Pierre Fabre Transaction PR Newswire
Dec-17-15 08:15AM  Array BioPharma (ARRY) Jumps: Stock Moves Up 20.6%
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib and Encorafenib for the treatment of cancer. Its drug candidates in Phase II clinical trials include Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASC08/Danoprevir, a protease inhibitor for Hepatitis C virus; ASLAN001/ARRY-543, a pan-HER inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; and LY2606368, a chk-1 inhibitor for cancer. The company's Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer; and ONT-380/ARRY-380, a HER2 inhibitor for breast cancer, as well as Phase I drug candidate includes GDC-0994, an ERK inhibitor for cancer and LOXO-101, a PanTrk inhibitor for cancer. Array BioPharma Inc. has collaboration agreements with Biogen Idec MA Inc.; Array and Celgene Corporation and Celgene Alpine Investment Co., LLC; Genentech, Inc.; Loxo Oncology, Inc.; Novartis International Pharmaceutical Ltd.; and Oncothyreon Inc, as well as a collaboration with Dana-Farber Cancer Institute. The company was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Redmile Group, LLC10% OwnerJan 12Buy3.6075,000270,00018,850,650Jan 14 04:14 PM
Redmile Group, LLC10% OwnerJan 11Buy3.54275,000973,50018,775,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 08Buy3.72350,0001,302,00018,500,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerJan 07Buy3.73300,0001,119,00018,150,650Jan 11 07:33 PM
Redmile Group, LLC10% OwnerOct 01Buy4.50100,140450,63018,033,102Oct 01 07:15 PM
Redmile Group, LLC10% OwnerSep 30Buy4.67182,452852,05117,932,962Oct 01 07:15 PM
Redmile Group, LLC10% OwnerSep 29Buy4.56500,0002,280,00017,750,510Oct 01 07:15 PM
Sandor VictorChief Medical OfficerSep 22Option Exercise5.1895,891496,715138,659Sep 24 02:01 PM